# Moleculin Biotech, Inc. (MBRX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MBRX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -12.85M | $ -6.11M | $ 185.0K | $ 15.18M |
| 2025 | $ 0 | $ -24.50M | $ -23.28M | $ 359.0K | $ 15.01M |
| 2024 | $ 0 | $ -22.87M | $ -25.09M | $ 478.0K | $ 5.98M |
| 2023 | $ 0 | $ -32.19M | $ -26.19M | $ 574.0K | $ 26.07M |
| 2022 | $ 0 | $ -32.42M | $ -30.95M | $ 451.0K | $ 52.19M |
| 2021 | $ 0 | $ -18.89M | $ -22.55M | $ 159.0K | $ 78.99M |
| 2020 | $ 0 | $ -22.11M | $ -23.12M | $ 277.0K | $ 17.76M |
| 2019 | $ 0 | $ -17.04M | $ -22.27M | $ 379.0K | $ 15.57M |
| 2018 | $ 0 | $ -15.68M | $ -16.67M | $ 0 | $ 14.27M |
| 2017 | $ 0 | $ -13.21M | $ -9.90M | $ 0 | $ 17.12M |
| 2016 | $ 0 | $ -5.76M | $ -5.20M | $ 296.4K | $ 14.96M |
| 2015 | $ 0 | $ -314.9K | $ -227 | $ 250.0K | $ -222.3K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.54 |
| Current Ratio | 1.38 |

## Other views

- [Metrics](https://sponda.capital/en/MBRX.md)
- [Charts](https://sponda.capital/en/MBRX/charts.md)
- [Compare](https://sponda.capital/en/MBRX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.